Veristat (the "Company"), a science-first full-service CRO and consultancy that advances complex therapies through the drug ...

Regulatory planning and development assessment encompass a coordinated suite of methodologies aimed at evaluating the impact, efficiency and equity of planning policies and regulatory interventions.

• Global regulatory harmonization would lower barriers for drug developers, but payers and, in many countries, health technology assessment bodies still determine if a drug that makes it to the market ...

The advent of artificial intelligence (AI) and data-driven methodologies has triggered a wave of transformation in regulatory compliance and quality assurance for the development of medical devices.

The pharmaceutical sector is experiencing growth through market expansion and global collaboration. To encourage this growth, compliance with regulations in Chemistry, Manufacturing, and Controls (CMC ...

The Food and Drug Administration (FDA) defines regulatory science as the science of developing new tools, standards, and approaches to assess the safety, effectiveness, quality, toxicity, public ...

You are the senior regulatory professional in the board room overseeing a major development program. The program looks promising and all you need to be concerned about is the most expeditious and risk ...

As electrification in the automotive industry becomes standard and the roll-out of software-defined vehicles (SDVs) gains extra mileage, technology complexity is becoming a key issue for the industry, ...

Let's start with the exciting news about tokenization-related activities. The SFC has issued two important circulars to address the risks and regulatory requirements in this area. The first one ...